StockNews.AISignal intelligence
Company intelligence

AVNS

Avanos Medical, Inc. · NYSE · Healthcare

Price$24.99+0.04% · +$0.01
Market cap1.17BEquity value
P / E27.8Trailing ratio
Volume432.16KLatest session
Market data

AVNS price chart

TradingView
Related signals
1 min delayed

Browse public AVNS signals with their source context and measured market impact. Open any signal for its permanent analysis page.

AVNSApr 14, 2026+69.41% since signal

Avanos agrees to all-cash acquisition at $25.00 per share

Avanos Medical, Inc. has entered a definitive agreement to be acquired by American Industrial Partners in an all-cash deal valued at $1.272 billion. The acquisition, offering significant premiums to current stock prices, is expected to close in the second half of 2026, marking a transition to a private company.

View signal analysis
AVNSMay 3, 2024-0.15% since signal

Avanos Medical (AVNS) Q1 Earnings Beat Estimates (Revised)

- Avanos Medical reported earnings of $0.22 per share, beating estimates and showing growth. - Company's revenues of $166.1 million exceeded expectations and have shown consistency in surpassing estimates. - Stock performance has declined but the future outlook may depend on earnings and industry trends. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

View signal analysis
Research

Company intelligence